Plasma B-type natriuretic peptide measurement in asymptomatic population

International Medical Journal

Volumn 10, Issue 2, 2003, Pages 105-108

  Matsuo, Shinro ^a   Nakamura, Yasuyuki ^a   Kinoshita, Masahiko ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Age; Asymptomatic; B type natriuretic peptide; Electrocardiography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PATIENT REFERRAL; PROTEIN BLOOD LEVEL; SYSTOLE;

EID: 0042812410     PISSN: 13412051     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332(6159): 78-81.
2. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96(2): 509-16.
3. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992; 92(1): 29-34.
4. Yamamoto K, Burnett JJ, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28(6): 988-94.
5. Sayama H, Nakamura Y, Saito N, Kinoshita M, Suda M. Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects. Gerontology 2000; 46(2): 71-7.
6. Yamada Y, Goto J, Yokota M. Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 1997; 88(5): 401-7.
7. Niinuma H, Nakamura M, Hiramori K. Plasma B-type natriuretic peptide measurement in a multiphasic health screening program. Cardiology 1998; 90(2): 89-94.
8. Matsuo S, Nakamura Y, Takahashi M, Mistunami K, Kinoshita M. Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia. Jpn Circ J 1998; 62: 167-172.
9. Shimada K, Kitazumi T, Sadakane N, Ogura H, Ozawa T. Age-related changes of baroreflex function, plasma norepinephrine, and blood pressure. Hypertension 1985; 7-1: 113-117.
10. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cell. Am J Physiol 1990; 259: H610-H618.
11. Matsuo S, Nakamura Y, Kinoshita M. Warfarin reduces silent cerebral infarction in elderly patients with atrial fibrillation. Coronary Artery Dis 1998; 9: 223-226.
12. Matsuo S, Takahashi M, Nakamura Y, Kinoshita M. Evaluation of cardiac sympathetic innervation with Iodine-123-Metaiodobenzylguanidine imaging in patients with silent myocardial ischemia. J Nucl Med 1996; 37: 712-717.
13. Kayden DS, Remetz MS, Cabin HS, Deckelbaum LI, Cleman MW, Wackers FJ, et al. Validation of continuous radionuclide left ventricular functioning monitoring in detecting silent myocardial ischemia during balloon angioplasty of the left anterior descending coronary artery. Am J Cardiol 1991; 67(16): 1339-43.
14. Lang CC, Prasad N, Macleod C, Lipworth BJ, MacDonald TM. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994; 127: 1635-1636.
15. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350(9081): 829-33.
16. Studies of left ventricular dysfunction (SOLVD) - rational, design, and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990; 66(3): 315-22.
17. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995.
18. Berendes E, Walter M, Cullen P, Prien T, Van AH, Horsthemke J, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997; 349(9047): 245-9.
19. Matsuo S, Nakamura Y, Tsutamoto T, Kinoshita M. Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy. J Nucl Cardiol 2002; 9(4): 407-12